@article{oai:repo.qst.go.jp:00082335,
 author = {H Fairley, Lauren and Sahara, Naruhiko and Aoki, Ichio and Ji, Bin and Suhara, Tetsuya and Higuchi, Makoto and M Barron, Anna and Naruhiko, Sahara and Ichio, Aoki and Ji, Bin and Tetsuya, Suhara and Makoto, Higuchi},
 issue = {1},
 journal = {Journal of neuroinflammation},
 month = {Mar},
 note = {The translocator protein (TSPO) has been identified as a positron emission tomography (PET)-visible biomarker of inflammation and promising immunotherapeutic target for the treatment of Alzheimer's disease (AD). While TSPO ligands have been shown to reduce the accumulation of the toxic Alzheimer's beta-amyloid peptide, their effect on tau pathology has not yet been investigated. To address this, we analyzed the effects of TSPO ligand, Ro5-4864, on the progression of neuropathology in rTg4510 tau transgenic mice (TauTg).},
 title = {Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy.},
 volume = {18},
 year = {2021}
}